HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation.
Giovanni CenderelloLucia TaramassoDomenico MarraPatrizia OrcamoAmbra PasaAntonio Di BiagioPublished in: Expert review of pharmacoeconomics & outcomes research (2018)
Treating the entire eligible HCV population would lead to significant benefits and savings in managing liver-related diseases and their direct costs, opening opportunities to re-think new settings for the future organization of liver disease management in the regional health system.